{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T01:25:57Z","timestamp":1788139557550,"version":"build-2803163510"},"reference-count":46,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"DOI":"10.1001\/jamaoncol.2018.5335","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T18:47:11Z","timestamp":1544122031000},"page":"e185335","source":"Crossref","is-referenced-by-count":49,"title":["Association of Chemoradiotherapy With Outcomes Among Patients With Stage I to II vs Stage III Small Cell Lung Cancer"],"prefix":"10.1001","volume":"5","author":[{"given":"Ahmed","family":"Salem","sequence":"first","affiliation":[{"name":"Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitesh","family":"Mistry","sequence":"additional","affiliation":[{"name":"Division of Pharmacy, University of Manchester, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hatton","sequence":"additional","affiliation":[{"name":"Weston Park Hospital, Sheffield, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imogen","family":"Locke","sequence":"additional","affiliation":[{"name":"Royal Marsden Hospital, Surrey, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Monnet","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Intercommunal de Cr\u00e9teil, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Blackhall","sequence":"additional","affiliation":[{"name":"Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Faivre-Finn","sequence":"additional","affiliation":[{"name":"Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2019,3,14]]},"reference":[{"key":"coi180096r1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/annonc\/mdp133","article-title":"Small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.","volume":"20","author":"S\u00f8rensen","year":"2009","journal-title":"Ann Oncol"},{"issue":"4","key":"coi180096r2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/0002-9343(69)90071-0","article-title":"Alkylating agents in bronchogenic carcinoma.","volume":"46","author":"Green","year":"1969","journal-title":"Am J Med"},{"issue":"4","key":"coi180096r3","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/annonc\/mdj094","article-title":"Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer.","volume":"17","author":"De Ruysscher","year":"2006","journal-title":"Ann Oncol"},{"issue":"8","key":"coi180096r4","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/S1470-2045(17)30318-2","article-title":"Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial.","volume":"18","author":"Faivre-Finn","year":"2017","journal-title":"Lancet Oncol"},{"issue":"23","key":"coi180096r5","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1056\/NEJM199212033272302","article-title":"A meta-analysis of thoracic radiotherapy for small-cell lung cancer.","volume":"327","author":"Pignon","year":"1992","journal-title":"N Engl J Med"},{"issue":"4","key":"coi180096r6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1056\/NEJM199901283400403","article-title":"Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide.","volume":"340","author":"Turrisi","year":"1999","journal-title":"N Engl J Med"},{"issue":"6","key":"coi180096r7","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1200\/JCO.1992.10.6.890","article-title":"Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? a meta-analysis.","volume":"10","author":"Warde","year":"1992","journal-title":"J Clin Oncol"},{"issue":"7","key":"coi180096r8","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1056\/NEJM199908123410703","article-title":"Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission.","volume":"341","author":"Aup\u00e9rin","year":"1999","journal-title":"N Engl J Med"},{"issue":"12","key":"coi180096r9","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1097\/JTO.0b013e31815bdc0d","article-title":"The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer.","volume":"2","author":"Shepherd","year":"2007","journal-title":"J Thorac Oncol"},{"issue":"9","key":"coi180096r10","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1097\/JTO.0b013e3181b27799","article-title":"The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer.","volume":"4","author":"Valli\u00e8res","year":"2009","journal-title":"J Thorac Oncol"},{"issue":"9","key":"coi180096r11","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1200\/JCO.1999.17.9.2681","article-title":"Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma.","volume":"17","author":"Bonner","year":"1999","journal-title":"J Clin Oncol"},{"issue":"15","key":"coi180096r12","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1056\/NEJM198704093161504","article-title":"Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung.","volume":"316","author":"Perry","year":"1987","journal-title":"N Engl J Med"},{"issue":"7","key":"coi180096r13","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3109\/02841869509127202","article-title":"Surgery for cure followed by chemotherapy in small cell carcinoma of the lung.","volume":"34","author":"Karrer","year":"1995","journal-title":"Acta Oncol"},{"issue":"11","key":"coi180096r14","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1097\/JTO.0b013e318189a860","article-title":"The role of surgery in the treatment of limited disease small cell lung cancer: time to reevaluate.","volume":"3","author":"Lim","year":"2008","journal-title":"J Thorac Oncol"},{"issue":"3","key":"coi180096r15","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/00000421-199106000-00008","article-title":"Surgery plus adjuvant chemotherapy for T1-3N0M0 small-cell lung cancer: rationale for current approach.","volume":"14","author":"Macchiarini","year":"1991","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"coi180096r16","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/S1010-7940(98)00203-6","article-title":"Long term results of surgery and chemotherapy in small cell lung cancer.","volume":"14","author":"Rea","year":"1998","journal-title":"Eur J Cardiothorac Surg"},{"issue":"5","key":"coi180096r17","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1002\/cncr.v116:5","article-title":"Survival outcomes with the use of surgery in limited-stage small cell lung cancer: should its role be re-evaluated?","volume":"116","author":"Schreiber","year":"2010","journal-title":"Cancer"},{"issue":"1","key":"coi180096r18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.lungcan.2015.01.010","article-title":"Role of surgical resection for patients with limited disease-small cell lung cancer.","volume":"88","author":"Takenaka","year":"2015","journal-title":"Lung Cancer"},{"issue":"5","key":"coi180096r19","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.jtcvs.2004.05.030","article-title":"Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101).","volume":"129","author":"Tsuchiya","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"coi180096r20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.lungcan.2017.04.021","article-title":"Surgery versus chemotherapy and radiotherapy for early and locally advanced small cell lung cancer: a propensity-matched analysis of survival.","volume":"109","author":"Wakeam","year":"2017","journal-title":"Lung Cancer"},{"issue":"10","key":"coi180096r21","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1200\/JCO.2015.63.8171","article-title":"Role of adjuvant therapy in a population-based cohort of patients with early-stage small-cell lung cancer.","volume":"34","author":"Yang","year":"2016","journal-title":"J Clin Oncol"},{"key":"coi180096r22","doi-asserted-by":"publisher","first-page":"vi99","DOI":"10.1093\/annonc\/mdt178","article-title":"Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.","volume":"24","author":"Fr\u00fch","year":"2013","journal-title":"Ann Oncol"},{"issue":"15","key":"coi180096r25","doi-asserted-by":"publisher","first-page":"288","DOI":"10.21037\/atm","article-title":"Resected small cell lung cancer-what do we do next?","volume":"4","author":"Marr","year":"2016","journal-title":"Ann Transl Med"},{"issue":"10","key":"coi180096r26","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1200\/JCO.2015.65.6462","article-title":"Using a population-based analysis to determine the management and treatment of early-stage small-cell lung cancer.","volume":"34","author":"Pietanza","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"coi180096r27","doi-asserted-by":"publisher","first-page":"e009849","DOI":"10.1136\/bmjopen-2015-009849","article-title":"Protocol for the CONVERT trial-Concurrent ONce-daily VErsus twice-daily RadioTherapy: an international 2-arm randomised controlled trial of concurrent chemoradiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status.","volume":"6","author":"Faivre-Finn","year":"2016","journal-title":"BMJ Open"},{"issue":"20","key":"coi180096r28","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"coi180096r30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"446","key":"coi180096r32","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"28","key":"coi180096r33","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1200\/JCO.2005.04.4859","article-title":"Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database.","volume":"24","author":"Govindan","year":"2006","journal-title":"J Clin Oncol"},{"issue":"16","key":"coi180096r34","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1200\/JCO.2004.11.089","article-title":"Positron emission tomography in limited-stage small-cell lung cancer: a prospective study.","volume":"22","author":"Bradley","year":"2004","journal-title":"J Clin Oncol"},{"issue":"6","key":"coi180096r35","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1097\/JTO.0b013e31824fe90a","article-title":"The efficacy of PET staging for small-cell lung cancer: a systematic review and cost analysis in the Australian setting.","volume":"7","author":"Ruben","year":"2012","journal-title":"J Thorac Oncol"},{"issue":"2","key":"coi180096r36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.lungcan.2011.03.013","article-title":"The role of positron emission tomography in management of small cell lung cancer.","volume":"73","author":"Thomson","year":"2011","journal-title":"Lung Cancer"},{"issue":"8","key":"coi180096r37","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.acra.2016.03.017","article-title":"Imaging for the pretreatment staging of small cell lung cancer: a systematic review.","volume":"23","author":"Mitchell","year":"2016","journal-title":"Acad Radiol"},{"issue":"6","key":"coi180096r38","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s12149-017-1178-z","article-title":"Prognostic value of pre-treatment 18F-FDG-PET uptake in small-cell lung cancer.","volume":"31","author":"Aktan","year":"2017","journal-title":"Ann Nucl Med"},{"issue":"7","key":"coi180096r39","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1158\/1078-0432.CCR-08-2258","article-title":"High tumor metabolic activity as measured by fluorodeoxyglucose positron emission tomography is associated with poor prognosis in limited and extensive stage small-cell lung cancer.","volume":"15","author":"Lee","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"2","key":"coi180096r40","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/JTO.0b013e3181c8cbf5","article-title":"Surgery for limited stage small cell lung cancer: time to fish or cut bait.","volume":"5","author":"Shepherd","year":"2010","journal-title":"J Thorac Oncol"},{"issue":"7820","key":"coi180096r41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0140-6736(73)93260-1","article-title":"Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus: ten-year follow-up.","volume":"2","author":"Fox","year":"1973","journal-title":"Lancet"},{"issue":"6","key":"coi180096r42","doi-asserted-by":"publisher","first-page":"320S","DOI":"10.1378\/chest.106.6_Supplement.320S","article-title":"A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small cell lung cancer to combination chemotherapy.","volume":"106","author":"Lad","year":"1994","journal-title":"Chest"},{"key":"coi180096r43","first-page":"CD011917","article-title":"Surgery for limited-stage small-cell lung cancer.","volume":"4","author":"Barnes","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"coi180096r44","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jtho.2016.09.133","article-title":"Prophylactic cranial irradiation for patients with surgically resected small cell lung cancer.","volume":"12","author":"Xu","year":"2017","journal-title":"J Thorac Oncol"},{"issue":"3","key":"coi180096r45","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.lungcan.2014.09.019","article-title":"Prophylactic cranial irradiation improved the overall survival of patients with surgically resected small cell lung cancer, but not for stage I disease.","volume":"86","author":"Zhu","year":"2014","journal-title":"Lung Cancer"},{"issue":"1","key":"coi180096r46","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1200\/JCO.1990.8.1.48","article-title":"Neurologic, computed cranial tomographic, and magnetic resonance imaging abnormalities in patients with small-cell lung cancer: further follow-up of 6- to 13-year survivors.","volume":"8","author":"Johnson","year":"1990","journal-title":"J Clin Oncol"},{"key":"coi180096r29","year":"2011"},{"key":"coi180096r23","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Small Cell Lung Cancer V.1. 2018.  https:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp#site. Accessed April 1, 2018."},{"key":"coi180096r24","unstructured":"National Institute for Health and Care Excellence. Lung cancer: diagnosis and management. 2011. https:\/\/www.nice.org.uk\/guidance\/cg121. Accessed April 1, 2018."},{"key":"coi180096r31","unstructured":"The National Cancer Institute. Common Terminology Criteria for Adverse Events version 3.0 (CTCAE v3.0). 2009. https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcaev3.pdf. Accessed July 21, 2017."}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamaoncology\/article-pdf\/5\/3\/e185335\/17345746\/jamaoncology_salem_2018_oi_180096.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T15:42:53Z","timestamp":1552578173000},"score":1,"resource":{"primary":{"URL":"http:\/\/oncology.jamanetwork.com\/article.aspx?doi=10.1001\/jamaoncol.2018.5335"}},"subtitle":["Secondary Analysis of a Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2019,3,14]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2018.5335","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3,14]]}}}